The Impact of Gut Bacteria Variability on Drug Efficacy: Insights from Wecare Probiotics
The intricate relationship between the gut microbiome and drug efficacy is gaining attention in the pharmaceutical industry, as highlighted during NutraIngredients' 2024 Probiota event. Nathan Price, Chief Scientific Officer at Thorne, emphasized the significant influence of gut bacteria on medication metabolism, suggesting that the microbiome is a critical factor in personalized medicine....
0 Comments
0 Shares
3159 Views